Nasdaq Rises While Dow Slumps

Jun 7, 2021 | Market Commentary

Friends
We had a slight reverse of fortune today as the NASDAQ posted gains while the Dow slumped just a bit. The shares of Biogen were the big winners as it was announced that the FDA approved the biotech firm’s Alzheimer’s drug, which is very exciting news. The markets in general, though, experienced a somewhat quiet day of trading.
By the close, the Dow Jones Industrial Average was down 126 points to finish the day at 34,630. The S&P 500 was down 3 points to close at 4,226. The Nasdaq Composite Index was up 67 points to close at 13,881. Gold was up $10 to trade at $1,902 per ounce, while oil was down $.42 to trade at $69.20 per barrel WTI.
The economic data point that is likely to receive the most attention this week is the CPI number released on Thursday. Inflation seems to be the item most on investors’ minds at the moment. Is it temporary or will it be long lasting? That is the question both the Fed and market participants want to know. Stay tuned.
Have a nice evening everyone.

Recent Posts

Tech Stocks Continue to Drag Market Lower

Tech Stocks Continue to Drag Market Lower

Friends The weakness in tech/AI stocks continues and the market averages, especially the Nasdaq, continue to lose ground as we get closer to year end. Instead of taking a victory lap the stocks that have been the leaders all year long are now cowering nervously in the...

Stocks Mostly Lower after Employment Data Release

Stocks Mostly Lower after Employment Data Release

Friends This morning’s release of the November non-farm payroll number showed that 64,000 new jobs were added, which was better than analysts had expected. The unemployment rate did tick up to 4.6%, which was actually more than expected. It’s hard to determine if this...

Stocks Soft As Economic Data Looms

Stocks Soft As Economic Data Looms

Friends Today was pretty much the same script we have seen over the past couple of weeks. The AI/big tech names came under selling pressure enough to take the market averages into negative territory. It’s hard to read too much into recent market action as we are so...